Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Inari Medical, Inc. NARI
$70.09
+$0.38 (0.55%)
На 18:02, 12 мая 2023
+25.55%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
3845980874.00000000
-
week52high
86.94
-
week52low
50.50
-
Revenue
383471000
-
P/E TTM
-124416
-
Beta
1.11625300
-
EPS
-0.52000000
-
Last Dividend
0.00000000
-
Next Earnings Date
01 авг 2023 г. в 10:59
Описание компании
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Morgan Stanley | Overweight | Overweight | 15 июл 2022 г. |
| BTIG | Buy | Buy | 24 июн 2022 г. |
| Piper Sandler | Overweight | 21 июн 2022 г. | |
| Canaccord Genuity | Buy | Buy | 14 мар 2022 г. |
| SVB Leerink | Outperform | Outperform | 24 февр 2022 г. |
| Canaccord Genuity | Buy | Buy | 16 сент 2022 г. |
| Truist Securities | Hold | 13 сент 2022 г. | |
| Berenberg | Buy | 29 сент 2022 г. | |
| Truist Securities | Hold | Hold | 17 окт 2022 г. |
| BTIG | Buy | Buy | 17 окт 2022 г. |
| Jefferies | Buy | 12 окт 2022 г. | |
| Morgan Stanley | Overweight | Overweight | 03 ноя 2022 г. |
| Morgan Stanley | Overweight | Overweight | 06 янв 2023 г. |
| Truist Securities | Hold | Hold | 20 дек 2022 г. |
| Truist Securities | Hold | Hold | 31 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Tu Thomas | D | 149584 | 10000 | 27 янв 2023 г. |
| Tu Thomas | D | 85700 | 300 | 27 янв 2023 г. |
| Tu Thomas | D | 86000 | 1100 | 27 янв 2023 г. |
| Tu Thomas | D | 87100 | 3071 | 27 янв 2023 г. |
| Tu Thomas | D | 90171 | 700 | 27 янв 2023 г. |
| Tu Thomas | D | 90871 | 2130 | 27 янв 2023 г. |
| Tu Thomas | D | 93001 | 2699 | 27 янв 2023 г. |
| Tu Thomas | A | 95700 | 10000 | 27 янв 2023 г. |
| Hykes Andrew | D | 93046 | 100 | 20 янв 2023 г. |
| Hykes Andrew | D | 93146 | 6900 | 20 янв 2023 г. |
Новостная лента
Inari Medical (NARI) Reports Solid Preliminary Q4 Revenues
Zacks Investment Research
12 янв 2023 г. в 13:33
Inari Medical's (NARI) revenue growth in the fourth quarter is likely to have been boosted by continued demand for its products, market expansion and new launches.
Strength Seen in Inari Medical, Inc. (NARI): Can Its 5.6% Jump Turn into More Strength?
Zacks Investment Research
11 янв 2023 г. в 08:17
Inari Medical, Inc. (NARI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
3 Remarkable Growth Stocks That Could Climb 39% to 46%, According to Wall Street
The Motley Fool
07 янв 2023 г. в 05:17
These companies are reporting financial results that aren't being reflected in their stock market performances.
Inari Medical to Present at the 41st Annual J.P. Morgan Healthcare Conference
GlobeNewsWire
21 дек 2022 г. в 16:01
IRVINE, Calif., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients suffering from venous and other diseases, announced today that its management team will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11th at 2:15PM Pacific Time.
Inari Medical: Retain Buy, No Change To Targets Despite Flat Price Action
Seeking Alpha
29 ноя 2022 г. в 05:52
Management raised FY22 revenue guidance to $373–$375mm, from a previous $360-$370mm. This followed a strong quarter with procedural growth across the portfolio.